RESPANA THERAPEUTICS RECEIVES SUPPORT FROM PENNSYLVANIA’S COVID-19 VACCINES, TREATMENTS AND THERAPIES (CV-VTT) PROGRAM Funding Will Be Used to Advance the Company’s Novel Monoclonal Antibody Philadelphia, PA – September 1, 2020. Respana Therapeutics is pleased to announce that it was one of 23 enterprises selected by the Commonwealth of Pennsylvania to receive a portion of the … Continue reading Press Release – September 1, 2020